Aramark Stock - weekly outlook with earnings ahead

Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/17/2026, 21:43 CET. Details in the imprint.

Aramark (US04206A1016) is entering the new trading week with a clear focus on its upcoming quarterly update and progress on debt reduction. After the 2023 spin-off of Vestis, the group is being judged more tightly on margins and free cash flow according to recent analyst commentary.

What the calendar shows

Aramark’s fiscal year ends on 09/27/2024, and the company last reported quarterly figures for Q2 of fiscal 2024 on 05/07/2024, posting revenue of $4.41 billion, up 5% year-over-year according to its quarterly filings.

For the coming months, the Philadelphia-based group has guided for continued organic revenue growth and gradual margin improvement, while emphasizing deleveraging as a strategic priority in its recent earnings presentation.

Analyst expectations into the week

On the Street, consensus compiled by financial data providers points to mid-single-digit revenue growth for Aramark in the current fiscal year, with adjusted earnings per share expected to rise at a double-digit percentage rate from the prior year, according to aggregated analyst estimates.

Major banks remain broadly constructive on the stock after the separation of the uniform business, seeing room for further debt reduction and operational efficiency gains across food and facilities services, based on recent broker research highlights.

The product behind the stock

Aramark generates most of its revenue by providing food-service and facilities-management solutions for clients such as universities, hospitals, sports stadiums and workplaces, including on-site catering, dining programs and support services across North America and selected international markets.

Where the stock trades today

Aramark shares (US04206A1016) most recently changed hands on the New York Stock Exchange at around $US price per share as of 06/17/2026, 21:43 CET.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.